Tocilizumab Treatment in Patients With COVID-19
Tocilizumab Treatment in Patients With COVID-19
Active, not recruiting · NCT04363853 · Registry updated 2026-04-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tocilizumab Treatment in Patients With COVID-19 | Sars-CoV2 | Active, not recruiting | Phase 2 | 2026-04-09 | NCT04363853 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Instituto Nacional de Cancerologia de Mexico | 17 |
| Roche Pharma AG | 59 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Cancer Institute of Mexico | Mexico City | Mexico | 2 |